Six patients (four with cystic fibrosis, two with bronchiectasis) harboured Pseudomonas aeruginosa in the lung before heart-lung transplantation. Three of the patients with cystic fibrosis were colonised by strains of different genotype postoperatively, and the colonisation tended to be short lived. (Thorax 1994;49:721-722) Department of Cardiac Surgery
Cystic fibrosis is characterised by abnormalities in ion transport affecting the epithelia and exocrine glands,"2 and this is probably the primary cause of recurrent infections in the lungs.2 Pseudomonas aeruginosa is the predominant pathogen associated with pulmonary infection and mortality in cystic fibrosis. 3 Heart-lung transplantation is an established treatment for patients with cystic fibrosis with end stage respiratory disease, and colonisation of allografts with Ps aeruginosa after heart-lung transplantation may adversely affect lung function. We have determined whether patients were colonised postoperatively with Ps aeruginosa strains which were resident before the operation.
Methods
Thirteen consecutive recipients of heart-lung transplantation were studied. Their underlying lung pathology included cystic fibrosis (five), non-cystic fibrosis bronchiectatic lung disease (four). All recipients with cystic fibrosis received appropriate antipseudomonas intravenous antibiotics for two weeks after heart-lung transplantation. Aerosolised colomycin was used as maintenance therapy after heart-lung transplantation and all patients with Ps aeruginosa in the lower airways during the first three months were 
Results
Of the 13 patients who underwent heart-lung transplantation six were found to be colonised with Ps aeruginosa after the operation (one six months after transplantation) and four of these had cystic fibrosis. Each of the patients with cystic fibrosis before operation was positive for Pseudomonas in the sputum, and in one case the organism was isolated from a nasal swab at the time of operation. The two non-cystic fibrosis bronchiectatic patients harboured Ps aeruginosa solely in the sputum preoperatively.
Three of the four patients with cystic fibrosis (nos 1, 2, and 4, table) were colonised postoperatively by strains of different genotype to those isolated before the operation (figure). Two of these patients had identical strains in both upper and lower airways, while the third harboured at least three distinct genotypes. The remaining patient with cystic fibrosis and the non-cystic fibrosis bronchiectatic patient (no. 5) retained a single strain throughout the sampling period.
Summary of DNA probe analysis of Ps aeruginosa isolates before and after heart-lung transplantation Patients Specimen Weeks before ( -) Genotype or after ()HLT During the first month after heart-1 transplantation three of the five cystic fibri patients in our study had Ps aeruginosa in b the upper and lower airways, and one acqui this organism in the lower airways only. contrast, patients with emphysema and I monary vascular disease did not become ( onised with Ps aeruginosa. Our finding of aeruginosa colonisation of the transplan lungs in cystic fibrosis during the early postoperative period was not associated with increased episodes of clinical infection. Smyth et a18 also found that the incidence of bronchitis and pneumonia with this organism was similar between recipients of heart-lung transplants with and without cystic fibrosis.
The native cystic fibrosis upper airways which retain the ion transport defect are a potential source of Ps aeruginosa contamination of the transplanted lower airways. The early use of aerosol and oral antipseudomonas antibiotics9 to prevent chronic Ps aeruginosa colonisation of lung allografts is supported by this study, as colonisation was found to be short lived.
The change in the Pseudomonas population after heart-lung transplantation shown in some 
